Art

J-GLOBAL ID：201402267650819703   Reference number：13A1963326

Efficacy and Economic Benefit of Combination Therapy with Boiogito and Methotrexate for the Treatment of Rheumatoid Arthritis

関節リウマチに対するメソトレキサートと防已黄耆湯の長期併用効果と経済的有用性

Author (2)： ONO SHUJI (大野クリニック(埼玉)) ,  AKIYAMA YUJI (埼玉医大 リウマチ・膠原病科)
Material： 日本東洋医学雑誌  (Kampo Medicine)
Volume： 64  Issue： 6  Page： 319-325  Publication year： Nov. 20, 2013 
JST Material Number： Z0304B  ISSN： 0287-4857  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human ,...
Semi thesaurus term： *rheumatoid arthritis ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A1963326&from=J-GLOBAL&jstjournalNo=Z0304B") }}

JST classification (3)： Clinical application of crude drugs  (GX06030U) ,  Clinical application of immunotherapeutic agents and blood preparations  (GW22020O) ,  Treatment for immunologic diseases,allergic diseases.  (GD04030Y)

Substance index (1)： Trimetrexate

Reference (13)：

• 1) Saag K.G, Teng G.G, Patker N.M, Anuntiyo J, Finney C, Curtis J.R, Paulus H.E, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison J.J, Almazor M.S, Bridges JR. S.L, Chatham W.W, Hochberg M, Maclean C, Mikulus T, Moreland L.W, O'Dell J, Turkiewicz A.M, and Furst D.E. :America College of Reumatorogy 2008 recommendations for use of nonbiologic and biologic disease modifying antirehmatic drugs in rheumatoid arthritis. Arthritis Rheum., 59:762-784, 2008
• 2) Smolen J.S, Landewe R, Breedveld F.C, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijilsma J.W, Bermesta G, Combe B, Cutolo M, Gabay C,Gomez-Reino J, Kuoloumas M, Kvien T.K, Martin-Mola E, Mclunnes I, Pavelka K, van Riel P, Scholte M, Scott D.L, Tuulikki S, Valesini G, van Vollenhoven R, Winthrop K.L, Wong J, Zink A, and van der Heijde D. : EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modefying antireumatic drugs. Ann. Rheum. Dis., 69:964-975, 2010.
• 3) 大野修嗣,鈴木輝彦:慢性関節リウマチに対するツムラ防己黄耆湯とLobenzarit の併用療法。臨床リウマチ,3(2):135-142,1991 7.
• 4) Pincus T, Yazici Y, Sokka T, Aleteha D, and Smolen J.S. : Methotrexate as the “anchor drug” for the treatment of early rheumatoid arthritis. Clin. exp. rheumatol 2003; 2 Suppl 3:S179
• 5) Smolen J.S, Aletaha D, Bijlsma J.W, Breedveld F.C, Boumpas D, Bermester G, Combe B, Cutolo M, Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino J.J, Haraoui B, Kalden J, Keystone E, Kvien T.K, Mclnnes I, Martin-Mola E, Montecucco C, Schoels M, and van der Heijde D. : T 2 T Expert Committee. Treating rheumatoid arthritis to target : recommendations of an international task force. Ann. Rheum. Dis69(4):631-637, 2010.Apr.

Terms in the title (6)： 関節リウマチ ,  防已黄耆湯 ,  長期 ,  併用効果 ,  経済 ,  有用性